Stay updated on BCG and ALT-803 Combo in Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the BCG and ALT-803 Combo in Bladder Cancer Clinical Trial page.

Latest updates to the BCG and ALT-803 Combo in Bladder Cancer Clinical Trial page
- Check4 days agoChange DetectedThe page now shows Revision: v3.4.3, replacing Revision: v3.4.2. This is an administrative version update with no substantive changes to content or data.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedThe old version shows Revision: v3.4.1 and the new version shows Revision: v3.4.2, a minor platform revision that does not affect study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check40 days agoChange DetectedRevision: v3.4.1 was added and v3.4.0 removed; this is a minor build/UI metadata change that does not affect study data or the history’s content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check47 days agoChange DetectedThe UI now displays a 'Show glossary' option and uses color-coded highlights to indicate additions and deletions, with the revision label updated to v3.4.0. There are minor capitalization updates in the 'No FEAR Act' labeling.SummaryDifference0.6%

- Check62 days agoChange DetectedA new revision entry (v3.3.4) was added to the page history, and the previous revision (v3.3.3) remains listed. This change does not affect study data, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check83 days agoChange DetectedA new 'Revision: v3.3.3' entry is added and the 'HHS Vulnerability Disclosure' link as well as the 'Revision: v3.3.2' entry are removed.SummaryDifference0.1%

Stay in the know with updates to BCG and ALT-803 Combo in Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BCG and ALT-803 Combo in Bladder Cancer Clinical Trial page.